Steve McQueen Film, PSA Brings Awareness to Mesothelioma

During the 90-minute feature documentary “Steve McQueen: American Icon,” audiences will reflect on the career of the “King of Cool” and discover the untold true story of the star’s late-in-life spiritual quest. They will also learn about mesothelioma — the rare cancer that killed McQueen at age 50 — and the dangers of asbestos. A public service announcement featuring Asbestos Disease Awareness Organization (ADAO) president and co-founder Linda Reinstein and Barbara McQueen, Steve’s widow, will air before encore screenings of the documentary on Oct. 10 and Oct. 19. Tickets and participating theaters for the encore showings are available at SteveMcQueenMovie.com. The PSA and documentary premiered Sept. 28 in nearly 800 theaters nationwide to an estimated 100,000 viewers. In the PSA, Reinstein and Barbara McQueen share educational resources, including facts that asbestos remains legal in the U.S. and kills more than 15,000 people each year. “Piggybacking an asbestos PSA onto a major film event gave us a huge platform for raising awareness, bringing our message to audiences in more than 800 theaters across the U.S.,” Reinstein told Asbestos.com. “And I think Steve’s powerful story will really drive home for folks just how real and tragic asbestos disease is.” Overwhelming interest in the film led the way to the encore showings, which will bring ADAO’s important message to thousands more. Film...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: “Steve McQueen American Icon alternative cancer treatments Asbestos Disease Awareness Organization asbestos marines asbestos public service announcement Barbara McQueen Billy Grah born-again Christian dangers of asbestos Don Schoonover Source Type: news

Related Links:

In this study, hyperuricemia was induced in rats by a 5-week high-purine diet. After that, DLE was administered continuously for 9 weeks. The result showed that biochemical parameters of liver and kidney function, especially serum uric acid (UA) levels, were significantly improved with DLE, which may relate to the reduction of xanthine oxidase (XOD) and adenosine deaminase (ADA) in the liver. Moreover, DLE could significantly prevent kidney and liver from damage, and intestinal injury and reduce inflammation in hyperuricemic rats by inhibiting the expression of both NF-κB and TLR4 proteins. These results showed that ...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Authors: Wang Y, Liu P, Fang Y, Tian J, Li S, Xu J, Zhao F, Yin X, Zhang Q, Li Y Abstract Objective: To explore the effect of long-term traditional Chinese medicine (TCM) treatment on survival time of colorectal cancer (hereinafter referred to as CRC). Methods: Our clinical study included patients who were diagnosed with CRC clinically or pathologically. Patients were divided into TCM treatment group and control group according to whether the modified Anti-cancer Decoction II Formula was applied for more than six months. Propensity score matching (hereinafter referred to as PSM) was used to further balance the ...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
In conclusion, findings from this retrospective cohort study indicated that integrated CHM and Western medicine could improve survival in patients with colorectal cancer. Additional research on integrating TCM with Western medicine to improve cancer survival is warranted. PMID: 32089722 [PubMed]
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Publication date: Available online 25 February 2020Source: Annals of Medicine and SurgeryAuthor(s): Gabriella Garruti, Michele De Fazio, Palma Capuano, Gennaro Martinez, Maria T. Rotelli, Francesco Puglisi, Nicola Palasciano, Francesco Giorgino
Source: Annals of Medicine and Surgery - Category: General Medicine Source Type: research
Publication date: Available online 26 February 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Mina Movahedian, Jessica Thomas, Jamal Rahmani, Cain C.T. Clark, Bahram Rashidkhani, Matin Ghanavati
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Conclusions: This practice parameter is a tool to guide technical use of proton therapy and does not assess the relative clinical indication of proton radiotherapy when compared with other forms of radiotherapy, but to focus on the best practices required to deliver proton therapy safely and effectively, when clinically indicated. Costs of proton treatments are high, and the economic costs of proton radiotherapy may also need to be considered.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Article: ACR-ASTRO Practice Parameter Source Type: research
No abstract available
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Editorial Source Type: research
Objectives: We sought to evaluate sociodemographic disparities in insurance coverage among nonelderly adults with a common cancer after Affordable Care Act (ACA) implementation. Patients and Methods: In total, 109,182 patients aged 18 to 64 years diagnosed with a common cancer (lung, breast, or prostate cancer) were identified from 2010 to 2014. Multivariable logistic regressions analyzed associations between ACA implementation and uninsured rates on the basis of state approach to Medicaid expansion, stratified by race (black, white), and income (stratified at 138% Federal Poverty Line). Results: Uninsured rates de...
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Health Policy Source Type: research
Objectives: We studied a cohort of cancer patients that underwent curative-intent radiation within the last year of life (LYOL). Given the unexpectedly short survival, we evaluated the proportion with relapsed/refractory disease, determined causes of death, and explored whether treatment intent was associated with aggressiveness of care at the end of life. Materials and Methods: We extracted and linked claims data and radiotherapy records for patients seen at a single academic institution that died between October 1, 2014, and September 30, 2015. Results: Among 870 cancer patients, 290 were irradiated within the LY...
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Health Policy Source Type: research
Purpose: NRG/RTOG 0848 was designed to determine whether adjuvant radiation with fluoropyrimidine sensitization improved survival following gemcitabine-based adjuvant chemotherapy for patients with resected pancreatic head adenocarcinoma. In step 1 of this protocol, patients were randomized to adjuvant gemcitabine versus the combination of gemcitabine and erlotinib. This manuscript reports the final analysis of these step 1 data. Methods: Eligibility—within 10 weeks of curative intent pancreaticoduodenectomy with postoperative CA19-9
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gastrointestinal Source Type: research
More News: Addiction | Alcoholism | Asbestosis | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Child Abuse | Childhood Cancer | Cough | Diets | Education | Environmental Health | Food and Drug Administration (FDA) | Heart | Learning | Legislation | Lessons | Lung Cancer | Men | Mesothelioma | Mexico Health | Nutrition | Sports Medicine | Substance Abuse | Toxicology | Universities & Medical Training | Urology & Nephrology